AmideBio’s proprietary technology enables the rapid and economical manufacture of pure peptides of any length. This innovative technology combines recombinant and chemical methods, eliminates many of the inefficient and costly steps of peptide manufacturing which results in fewer batch inconsistencies and less waste generation. Such advantages offer AmideBio multiple opportunities to offer technology and cost benefits to the pharmaceutical and biotech industry as well as the ability to produce complex peptides for SAR studies. AmideBio holds patents for the core technology and a number of therapeutics that have been leveraged by this technology.
Contact us today to see how we can provide a more efficient and lower cost solution to your peptide manufacturing problem.